- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Cuprina Prices 4.32 Mln Share Offering At $1.15/shr | 1 | RTTNews | ||
| Mi | Cuprina prices $5M public offering | 3 | Seeking Alpha | ||
| Mi | Cuprina Holdings (Cayman) Limited Announces Pricing of $4.97 million Public Offering | 2 | GlobeNewswire (USA) | ||
| Fr | Cuprina Holdings LTD - F-1/A, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| CUPRINA HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 07.07. | Cuprina Holdings LTD - F-1, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 24.06. | Morning Market Movers: Cuprina Holdings, CEA Industries, Absci, The Wendy's Company See Big Swings | 1.011 | AFX News | MEMPHIS (dpa-AFX) - At 7:10 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 16.06. | Cuprina Holdings Falls 22% After 112% Rally - Here's Why CUPR Stock Is Trending | 4 | Benzinga.com | ||
| 15.06. | Cuprina erhält FDA-Zulassung für Produkt zur Madentherapie | 8 | Investing.com Deutsch | ||
| 15.06. | Cuprina receives FDA clearance for maggot wound therapy product | 1 | Investing.com | ||
| 15.06. | Cuprina Holdings (Cayman) LTD: Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots - the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product | 409 | GlobeNewswire (Europe) | SINGAPORE, June 15, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("CUPR" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 12.06. | Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements | 507 | GlobeNewswire (Europe) | SINGAPORE, June 12, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 12.06. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.05. | Cuprina requests Nasdaq hearing after delisting notice | 2 | Investing.com | ||
| 29.05. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing | 254 | GlobeNewswire (Europe) | SINGAPORE, May 29, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings Cayman Limited Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 22.05. | Cuprina to implement 1-for-8 share consolidation to address Nasdaq compliance | 1 | Seeking Alpha | ||
| 22.05. | Cuprina plant Aktienzusammenlegung im Verhältnis 1:8 zur Sicherung der NASDAQ-Notierung | 5 | Investing.com Deutsch | ||
| 22.05. | Cuprina plans 1-for-8 reverse stock split to meet Nasdaq rules | 1 | Investing.com | ||
| 22.05. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings announces 1-for-8 Share Consolidation | 441 | GlobeNewswire (Europe) | SINGAPORE, May 22, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 14.05. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.04. | Cuprina Holdings LTD - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,614 | +0,07 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,068 | +5,56 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| CERENOME | 1,680 | -4,65 % | Cerenome, Inc.: Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division | HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announces the appointment of Samantha... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,140 | +1,90 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | -2,61 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,960 | +2,04 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| QUIDELORTHO | 9,278 | +1,82 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,380 | +2,59 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| LIFEWARD | 6,910 | 0,00 % | Lifeward legt Termin für jährliche und außerordentliche Hauptversammlung 2026 fest | ||
| CLOVER HEALTH INVESTMENTS | 3,940 | -0,76 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| SENSEONICS | 7,850 | -0,63 % | Senseonics sees activist investor take a major stake | ||
| TEMPEST THERAPEUTICS | 0,974 | -19,50 % | Tempest Therapeutics: Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform | -Transaction complements Tempest's existing CD7-targeted lipid nanoparticle in vivo CAR-T delivery platform, which is planned to enter the clinic later this year -Lead BCMA/GPRC5D dual-targeting in... ► Artikel lesen | |
| NANO-X IMAGING | 0,760 | +0,85 % | Nano-X Imaging Ltd: Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica | Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative... ► Artikel lesen | |
| IMUNON | 1,230 | -1,60 % | Imunon, Inc.: IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001 |
Das Unternehmen CUPRINA HOLDINGS CAYMAN LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,730 Euro und damit +8,12 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CUPRINA HOLDINGS CAYMAN LIMITED finden Sie auf Wallstreet Online.